Latest Insider Transactions at Honest Company, Inc. (HNST)
This section provides a real-time view of insider transactions for Honest Company, Inc. (HNST). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Honest Company, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Honest Company, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 20
2024
|
Carla Vernon Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
65,176
-2.3%
|
$456,232
$7.1 P/Share
|
|
Nov 20
2024
|
Katherine Barton Chief Growth Officer |
SELL
Open market or private sale
|
Direct |
23,884
-2.61%
|
$167,188
$7.1 P/Share
|
|
Nov 20
2024
|
Brendan Sheehey General Counsel |
SELL
Open market or private sale
|
Direct |
8,392
-1.6%
|
$58,744
$7.1 P/Share
|
|
Nov 20
2024
|
David Loretta Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
27,004
-2.73%
|
$189,028
$7.1 P/Share
|
|
Nov 20
2024
|
Thomas Sternweis SVP, Enterprise Dev. & Strat. |
SELL
Open market or private sale
|
Direct |
1,515
-0.64%
|
$10,605
$7.1 P/Share
|
|
Nov 20
2024
|
Stephen Winchell EVP, Operations and R&D |
SELL
Open market or private sale
|
Direct |
7,123
-1.83%
|
$49,861
$7.1 P/Share
|
|
Nov 20
2024
|
Jonathan Mayle SVP, Customer Sales |
SELL
Open market or private sale
|
Direct |
2,332
-0.84%
|
$16,324
$7.1 P/Share
|
|
Nov 18
2024
|
Brendan Sheehey General Counsel |
SELL
Open market or private sale
|
Direct |
107,653
-9.36%
|
$753,571
$7.01 P/Share
|
|
Nov 18
2024
|
Brendan Sheehey General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
115,000
+9.08%
|
$575,000
$5.66 P/Share
|
|
Nov 18
2024
|
Stephen Winchell EVP, Operations and R&D |
SELL
Open market or private sale
|
Direct |
25,000
-6.03%
|
$175,000
$7.08 P/Share
|
|
Nov 15
2024
|
Jonathan Mayle SVP, Customer Sales |
SELL
Open market or private sale
|
Direct |
21,000
-7.04%
|
$126,000
$6.5 P/Share
|
|
Sep 18
2024
|
Thc Shared Abacus, LP |
SELL
Open market or private sale
|
Direct |
2,300,000
-18.9%
|
$6,900,000
$3.5 P/Share
|
|
Aug 21
2024
|
David Loretta Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
75,656
-7.11%
|
$302,624
$4.28 P/Share
|
|
Aug 21
2024
|
Stephen Winchell EVP, Operations and R&D |
SELL
Open market or private sale
|
Direct |
6,938
-1.65%
|
$27,752
$4.28 P/Share
|
|
Aug 21
2024
|
Thomas Sternweis SVP, Enterprise Dev. & Strat. |
SELL
Open market or private sale
|
Direct |
1,481
-0.62%
|
$5,924
$4.28 P/Share
|
|
Aug 21
2024
|
Katherine Barton Chief Growth Officer |
SELL
Open market or private sale
|
Direct |
16,185
-1.73%
|
$64,740
$4.28 P/Share
|
|
Aug 21
2024
|
Carla Vernon Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
52,751
-1.83%
|
$211,004
$4.28 P/Share
|
|
Aug 21
2024
|
Jonathan Mayle SVP, Customer Sales |
SELL
Open market or private sale
|
Direct |
8,865
-2.88%
|
$35,460
$4.28 P/Share
|
|
Aug 21
2024
|
Brendan Sheehey General Counsel |
SELL
Open market or private sale
|
Direct |
8,176
-1.55%
|
$32,704
$4.28 P/Share
|
|
Aug 13
2024
|
James D White Director |
SELL
Open market or private sale
|
Direct |
70,000
-18.46%
|
$210,000
$3.98 P/Share
|
|
May 22
2024
|
James D White Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,569
+13.77%
|
-
|
|
May 22
2024
|
Susan Gentile Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,569
+20.22%
|
-
|
|
May 22
2024
|
Jack Hartung Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,569
+15.71%
|
-
|
|
May 22
2024
|
Andrea Turner Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,569
+21.2%
|
-
|
|
May 22
2024
|
Jessica Warren Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,569
+4.92%
|
-
|
|
May 22
2024
|
Honest Company, Inc. Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,569
+21.2%
|
-
|
|
May 22
2024
|
Alissa Hsu Lynch Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,569
+21.2%
|
-
|
|
May 22
2024
|
Katie J Bayne Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,569
+16.92%
|
-
|
|
May 21
2024
|
Brendan Sheehey General Counsel |
SELL
Open market or private sale
|
Direct |
8,583
-1.61%
|
$17,166
$2.77 P/Share
|
|
May 21
2024
|
Carla Vernon Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
43,317
-1.48%
|
$86,634
$2.77 P/Share
|
|
May 21
2024
|
Thomas Sternweis SVP, Enterprise Dev. & Strat. |
SELL
Open market or private sale
|
Direct |
10,047
-4.06%
|
$20,094
$2.77 P/Share
|
|
May 21
2024
|
Stephen Winchell EVP, Operations and R&D |
SELL
Open market or private sale
|
Direct |
7,283
-1.7%
|
$14,566
$2.77 P/Share
|
|
May 21
2024
|
Katherine Barton Chief Growth Officer |
SELL
Open market or private sale
|
Direct |
67,930
-6.79%
|
$135,860
$2.77 P/Share
|
|
Apr 19
2024
|
Jessica Warren Director |
SELL
Open market or private sale
|
Direct |
253,815
-18.62%
|
$507,630
$2.99 P/Share
|
|
Apr 18
2024
|
Jessica Warren Director |
SELL
Open market or private sale
|
Direct |
265,820
-16.32%
|
$797,460
$3.06 P/Share
|
|
Apr 17
2024
|
Jessica Warren Director |
SELL
Open market or private sale
|
Direct |
276,113
-14.49%
|
$828,339
$3.07 P/Share
|
|
Mar 18
2024
|
Carla Vernon Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
209,160
-6.67%
|
$836,640
$4.16 P/Share
|
|
Mar 07
2024
|
Brendan Sheehey General Counsel |
SELL
Open market or private sale
|
Direct |
21,152
-3.81%
|
$63,456
$3.24 P/Share
|
|
Mar 07
2024
|
Jessica Warren Director |
SELL
Open market or private sale
|
Direct |
23,324
-1.21%
|
$69,972
$3.24 P/Share
|
|
Mar 07
2024
|
Stephen Winchell EVP, Operations and R&D |
SELL
Open market or private sale
|
Direct |
19,665
-4.38%
|
$58,995
$3.24 P/Share
|
|
Feb 29
2024
|
Jessica Warren Director |
BUY
Grant, award, or other acquisition
|
Direct |
963,494
+33.32%
|
-
|
|
Feb 29
2024
|
Brendan Sheehey General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
157,370
+22.07%
|
-
|
|
Feb 29
2024
|
Katherine Barton Chief Growth Officer |
BUY
Grant, award, or other acquisition
|
Direct |
157,370
+13.59%
|
-
|
|
Feb 29
2024
|
David Loretta Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
236,056
+18.17%
|
-
|
|
Feb 29
2024
|
Carla Vernon Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,188,309
+27.5%
|
-
|
|
Feb 29
2024
|
Stephen Winchell EVP, Operations and R&D |
BUY
Grant, award, or other acquisition
|
Direct |
157,370
+25.97%
|
-
|
|
Feb 29
2024
|
Dorria L. Ball Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
208,757
+50.0%
|
-
|
|
Jan 03
2024
|
Jessica Warren Director |
SELL
Open market or private sale
|
Direct |
50,659
-4.99%
|
$101,318
$2.94 P/Share
|
|
Jan 02
2024
|
Brendan Sheehey General Counsel |
SELL
Open market or private sale
|
Direct |
4,495
-1.12%
|
$13,485
$3.18 P/Share
|
|
Jan 01
2024
|
Katie J Bayne Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,334
+12.02%
|
$64,668
$2.47 P/Share
|